LOW-DOSE-RATE IODINE-125 SEEDS BRACHYTHERAPY: PSA NADIR LESS THAN 1 NG/ML AS PROGNOSTIC FACTOR.

被引：1
|
作者：
Reis, Leonardo O.
Monti, C. R.
Castilho, Lisias N.
Gialluca, V. D.
Reinato, Jose A. S.
Uhmann, E.
Kawakami, N. S.
Ferreira, Ubirajara
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 04期
关键词：
D O I：
10.1016/j.juro.2010.02.2087
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
2041
引用
收藏
页码：E792 / E793
页数：2
相关论文
共 36 条
  • [31] Low-dose rate stereotactic iodine-125 brachytherapy for the treatment of inoperable primary and recurrent glioblastoma: single-center experience with 201 cases
    Philipp Kickingereder
    Christina Hamisch
    Bogdana Suchorska
    Norbert Galldiks
    Veerle Visser-Vandewalle
    Roland Goldbrunner
    Martin Kocher
    Harald Treuer
    Juergen Voges
    Maximilian I. Ruge
    Journal of Neuro-Oncology, 2014, 120 : 615 - 623
  • [32] Patients with PSA below 0.2?ng/mL at 8?years post high-dose-rate brachytherapy have an extremely low risk of subsequent recurrence
    Nakazono, Minoru
    Urabe, Fumihiko
    Iwatani, Kosuke
    Imai, Yu
    Tashiro, Kojiro
    Honda, Mariko
    Koike, Yusuke
    Shimomura, Tatsuya
    Sato, Shun
    Takahashi, Hiroyuki
    Miki, Kenta
    Aoki, Manabu
    Kimura, Takahiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (12) : 1147 - 1154
  • [33] The potential of low-dose-rate brachytherapy with iodine-1 25 in the treatment of local recurrences of prostate cancer after primary high-dose-rate monotherapy
    Burchardt, Wojciech M.
    Chyrek, Artur J.
    Bieleda, Grzegorz M.
    Burchardt, Ewa
    Chichel, Adam
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2023, 15 (02) : 103 - 109
  • [34] Postoperative Stimulated Thyroglobulin of Less Than 1 ng/mL as a Criterion to Spare Low-Risk Patients with Papillary Thyroid Cancer from Radioactive Iodine Ablation
    Rosario, Pedro Weslley
    Campos Mineiro Filho, Augusto Flavio
    Senna Prates, Brenda Sa
    Oliveira Silva, Livia Cristina
    Calsolari, Maria Regina
    THYROID, 2012, 22 (11) : 1140 - 1143
  • [35] Patient-reported health-related quality of life for men treated with low-dose-rate prostate brachytherapy as monotherapy with 125-iodine, 103-palladium, or 131-cesium: Results of a prospective phase II study
    Blanchard, Pierre
    Pugh, Thomas J.
    Swanson, David A.
    Mahmood, Usama
    Chen, Hsiang-Chun
    Wang, Xuemei
    Graber, William J.
    Kudchadker, Rajat J.
    Bruno, Teresa
    Feeley, Thomas
    Frank, Steven J.
    BRACHYTHERAPY, 2018, 17 (02) : 265 - 276
  • [36] Failure to achieve PSA level less than or equal to 1 ng/ml following neo-adjuvant LHRHa therapy predicts for a lower rate of biochemical control and lower overall survival in localised prostate cancer treated with radiation therapy
    Mitchell, D. M.
    McAleese, J.
    Park, R. M.
    Stewart, D. R.
    Stranex, S.
    Eakin, R.
    Houston, R. F.
    O'Sullivan, J. M.
    EJC SUPPLEMENTS, 2007, 5 (04): : 292 - 292
1234